Analysts Slash Fiserv Forecasts After Q1 Miss, Raising Stakes for Q2 Trough

What happened

Fiserv reported mixed Q1 results with GAAP revenue down 2% YoY and organic revenue falling 4%, while adjusted operating margin plunged to 29.7% from 37.8%, driven by $142M in One Fiserv transformation costs and higher partner payments. In response, analysts have slashed their forecasts, amplifying skepticism that the company's "repair year" narrative will deliver a meaningful recovery. Management reaffirmed FY26 guidance and called Q2 the "trough" for revenue declines, but the Q1 miss makes that call harder to trust. Clover volume growth of 12% ex-gateway and VAS mix at 27% of revenue offer some positive signals, but Financial Solutions organic decline of 6% and margin compression overshadow them. The stock at $65.70 trades at ~9.6x P/E, but without clear proof of stabilization by Q2 results, the cheap valuation risks becoming a value trap.

Implication

Over 6-12 months, the stock can re-rate to $75-80 if Q2 validates inflection and the May 14 Investor Day provides concrete KPIs. But risk of structural margin erosion or persistent revenue decline could push value to $62. Monitor Q2 earnings and transformation cost trajectory before committing capital.

Thesis delta

The analyst forecast cuts intensify the burden of proof on management's Q2 trough claim. The 'transition-year' framing is still valid but the margin for error has narrowed; if Q2 organic revenue does not improve sequentially, the base case shifts from temporary reset to structural slowing. The bull case depends on Clover VAS growth and cost tapering, but these are now less certain.